{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:10:02Z","timestamp":1759176602705,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jhep.2012.03.020","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T15:08:05Z","timestamp":1334675285000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Sylvie","family":"Deuffic-Burban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.03.020_b0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/hep.21902","article-title":"Acute hepatitis C virus infection: a chronic problem","volume":"47","author":"Blackard","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.03.020_b0015","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2174\/138161208784746851","article-title":"Therapy of acute hepatitis C: a review of literature","volume":"14","author":"Santantonio","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhep.2012.03.020_b0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.03.020_b0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkn346","article-title":"Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha","volume":"62","author":"Wiegand","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2012.03.020_b0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2893.2009.01167.x","article-title":"Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis","volume":"17","author":"Corey","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.03.020_b0035","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/429490","article-title":"Acute hepatitis C virus infection","volume":"41","author":"Chung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2004.02023.x","article-title":"Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response","volume":"20","author":"Delwaide","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2012.03.020_b0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"Hofer","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0050","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.03.020_b0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.03.020_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2011.04.005","article-title":"A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection","volume":"141","author":"Knapp","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.03.020_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","article-title":"Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes","volume":"52","author":"Montes-Cano","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jhep.2001.22112","article-title":"Acute hepatitis C","volume":"33","author":"Orland","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0075","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/507640","article-title":"Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy","volume":"43","author":"Santantonio","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0085","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.jhep.2012.03.020_b0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.20742","article-title":"Viral and host factors in early hepatitis C virus infection","volume":"42","author":"Mosley","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840190105","article-title":"A multicenter randomized controlled trial of recombinant interferon-alpha2b in patients with acute transfusion-associated hepatitis C","volume":"19","author":"Lampertico","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection","volume":"52","author":"Grebely","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0110","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.03.020_b0120","first-page":"1609","article-title":"Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion","volume":"335","author":"Courouce","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.03.020_b0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.03.020_b0130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.03.020_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2005.00653.x","article-title":"Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins","volume":"13","author":"Sarobe","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.03.020_b0145","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","article-title":"Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells","volume":"82","author":"Badr","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.03.020_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-832922","article-title":"The natural history of hepatitis C","volume":"24","author":"Afdhal","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0155","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.21365","article-title":"Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence","volume":"44","author":"Golden-Mason","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0160","first-page":"212","article-title":"Factors influencing natural history of chronic hepatitis C","volume":"7","author":"Kryczka","year":"2001","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jhep.2012.03.020_b0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.03.020_b0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.03.020_b0175","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jmv.20103","article-title":"High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection","volume":"73","author":"Lehmann","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2012.03.020_b0185","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2004.02.041","article-title":"Acute hepatitis C virus infection: to treat or not to treat?","volume":"126","author":"Jaeckel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.03.020_b0190","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jmv.20392","article-title":"Surveillance of acute hepatitis C in Cairo, Egypt","volume":"76","author":"El Gaafary","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2012.03.020_b0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1590-8658(03)00007-0","article-title":"Natural course of acute hepatitis C: a long-term prospective study","volume":"35","author":"Santantonio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0205","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1086\/651599","article-title":"Prospective follow-up of patients with acute hepatitis C virus infection in Brazil","volume":"50","author":"Lewis-Ximenez","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria","volume":"49","author":"McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2012.03.020_b0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3851\/IMP1501","article-title":"Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort","volume":"15","author":"Vogel","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2012.03.020_b0220","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.03.020_b0225","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3851\/IMP1843","article-title":"Pegylated interferon-alpha monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C","volume":"16","author":"Arends","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2012.03.020_b0230","unstructured":"Boesecke C, Stellbrink H-J, Mauss S, Page E, Nelson M, Bhagani S, et al. Does baseline HCV genotype have an impact upon treatment outcome of acute HCV infection in HIV co-infected individuals? In: 18th conference on retroviruses and opportunistic infections, February 27\u2013March 2, 2011, Boston, USA."},{"key":"10.1016\/j.jhep.2012.03.020_b0235","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/587843","article-title":"Impact of HIV on host-virus interactions during early hepatitis C virus infection","volume":"197","author":"Danta","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:32:07Z","timestamp":1759174327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812002759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0168827812002759"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.03.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"type":"print","value":"0168-8278"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2012.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}